Joseph Lewis - Net Worth and Insider Trading
Joseph Lewis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joseph Lewis owns 15 companies in total, including Odonate Inc (ODTC) , PMV Pharmaceuticals Inc (PMVP) , and ITeos Therapeutics Inc (ITOS) among others .
Click here to see the complete history of Joseph Lewis’s form 4 insider trades.
Insider Ownership Summary of Joseph Lewis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ODTC | Odonate Inc | 2017-12-06 | 10 percent owner |
| PMVP | PMV Pharmaceuticals Inc | 2020-09-24 | 10 percent owner |
| ITOS | ITeos Therapeutics Inc | 2023-08-23 | other: See remarks |
 | | 2020-07-21 | 10 percent owner |
| | 2023-09-29 | 10 percent owner |
| | 2019-03-04 | 10 percent owner |
| | 2018-10-26 | 10 percent owner |
| | 2023-08-11 | other: See remarks |
| | 2016-06-02 | 10 percent owner |
| | 2014-12-15 | 10 percent owner |
| | 2013-05-20 | 10 percent owner |
| | 2023-05-22 | other: See remarks. |
| | 2023-08-11 | other: See remarks |
| | 2021-09-14 | 10 percent owner |
| | 2016-06-02 | 10 percent owner |
Joseph Lewis Trading Performance
Joseph Lewis Ownership Network
Joseph Lewis Owned Company Details
What does Odonate Inc do?
Who are the key executives at Odonate Inc?
Joseph Lewis is the 10 percent owner of Odonate Inc. Other key executives at Odonate Inc include 10 percent owner Ecor1 Capital, Llc , director & 10 percent owner Boxer Capital, Llc , and director & 10 percent owner & Chief Executive Officer Kevin C Tang .
Odonate Inc (ODTC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Odonate Inc (ODTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Odonate Inc (ODTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Odonate Inc (ODTC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Odonate Inc Insider Transactions
- Download to Excel(.xls)
What does PMV Pharmaceuticals Inc do?
Who are the key executives at PMV Pharmaceuticals Inc?
Joseph Lewis is the 10 percent owner of PMV Pharmaceuticals Inc. Other key executives at PMV Pharmaceuticals Inc include SVP & Regulatory Affairs and QA Deepika Jalota , 10 percent owner Orbimed Advisors Llc , and Chief Medical Officer Leila Alland .
PMV Pharmaceuticals Inc (PMVP) Insider Trades Summary
Over the past 18 months, Joseph Lewis made no insider transaction in PMV Pharmaceuticals Inc (PMVP). Other recent insider transactions involving PMV Pharmaceuticals Inc (PMVP) include a net sale of 11,322 shares made by Deepika Jalota , a net sale of 87,786 shares made by Orbimed Advisors Llc , and a net sale of 6,291 shares made by Leila Alland .
In summary, during the past 3 months, insiders sold 0 shares of PMV Pharmaceuticals Inc (PMVP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 108,290 shares of PMV Pharmaceuticals Inc (PMVP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 108,290 shares.
PMV Pharmaceuticals Inc (PMVP)'s detailed insider trading history can be found in Insider Trading Tracker table.
PMV Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does ITeos Therapeutics Inc do?
Who are the key executives at ITeos Therapeutics Inc?
Joseph Lewis is the other: See remarks of ITeos Therapeutics Inc. Other key executives at ITeos Therapeutics Inc include Chief Financial Officer Matthew Gall , other: See remarks Boxer Asset Management Inc. , and other: See remarks Boxer Capital, Llc .
ITeos Therapeutics Inc (ITOS) Insider Trades Summary
Over the past 18 months, Joseph Lewis made no insider transaction in ITeos Therapeutics Inc (ITOS). Other recent insider transactions involving ITeos Therapeutics Inc (ITOS) include a net purchase of 10,000 shares made by Matthew Gall , and a net sale of 350,000 shares made by Boxer Capital, Llc .
In summary, during the past 3 months, insiders sold 0 shares of ITeos Therapeutics Inc (ITOS) in total and bought 5,000 shares, with a net purchase of 5,000 shares. During the past 18 months, 350,000 shares of ITeos Therapeutics Inc (ITOS) were sold and 10,000 shares were bought by its insiders, resulting in a net sale of 340,000 shares.
ITeos Therapeutics Inc (ITOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
ITeos Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Pandion Therapeutics Inc do?
Who are the key executives at Pandion Therapeutics Inc?
Joseph Lewis is the 10 percent owner of Pandion Therapeutics Inc. Other key executives at Pandion Therapeutics Inc include director & 10 percent owner Daniel J. Becker , 10 percent owner Mva Investors, Llc , and 10 percent owner Polaris Partners VIII, L.P. .
Pandion Therapeutics Inc (PAND) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Pandion Therapeutics Inc (PAND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pandion Therapeutics Inc (PAND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Pandion Therapeutics Inc (PAND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pandion Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Inseego Corp do?
Who are the key executives at Inseego Corp?
Joseph Lewis is the 10 percent owner of Inseego Corp. Other key executives at Inseego Corp include 10 percent owner Tavistock Financial, Llc , Chief Financial Officer Steven Gatoff , and President and CEO Dan Mondor .
Inseego Corp (INSG) Insider Trades Summary
Over the past 18 months, Joseph Lewis made no insider transaction in Inseego Corp (INSG). Other recent insider transactions involving Inseego Corp (INSG) include a net purchase of 10,000 shares made by Philip G Brace ,
In summary, during the past 3 months, insiders sold 0 shares of Inseego Corp (INSG) in total and bought 10,000 shares, with a net purchase of 10,000 shares. During the past 18 months, 0 shares of Inseego Corp (INSG) were sold and 10,000 shares were bought by its insiders, resulting in a net purchase of 10,000 shares.
Inseego Corp (INSG)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inseego Corp Insider Transactions
- Download to Excel(.xls)
What does Solid Biosciences Inc do?
Who are the key executives at Solid Biosciences Inc?
Joseph Lewis is the 10 percent owner of Solid Biosciences Inc. Other key executives at Solid Biosciences Inc include Chief Technology Officer Paul Herzich , Chief Regulatory Officer Jessie Hanrahan , and See Remarks David T Howton .
Solid Biosciences Inc (SLDB) Insider Trades Summary
Over the past 18 months, Joseph Lewis made no insider transaction in Solid Biosciences Inc (SLDB). Other recent insider transactions involving Solid Biosciences Inc (SLDB) include a net sale of 1,743 shares made by Ilan Ganot , a net sale of 10,439 shares made by David T Howton , and a net sale of 9,489 shares made by Jessie Hanrahan .
In summary, during the past 3 months, insiders sold 26,496 shares of Solid Biosciences Inc (SLDB) in total and bought 0 shares, with a net sale of 26,496 shares. During the past 18 months, 50,278 shares of Solid Biosciences Inc (SLDB) were sold and 4,315,973 shares were bought by its insiders, resulting in a net purchase of 4,265,695 shares.
Solid Biosciences Inc (SLDB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Solid Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does Esperion Therapeutics Inc do?
Who are the key executives at Esperion Therapeutics Inc?
Joseph Lewis is the 10 percent owner of Esperion Therapeutics Inc. Other key executives at Esperion Therapeutics Inc include Chief Financial Officer Benjamin Halladay , Chief Operating Officer Sheldon L. Koenig , and Chief Commercial Officer Eric Warren .
Esperion Therapeutics Inc (ESPR) Insider Trades Summary
Over the past 18 months, Joseph Lewis made no insider transaction in Esperion Therapeutics Inc (ESPR). Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 9,288 shares made by Eric Warren , a net sale of 26,997 shares made by Sheldon L. Koenig , and a net sale of 4,202 shares made by Joanne M. Foody .
In summary, during the past 3 months, insiders sold 18,230 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 18,230 shares. During the past 18 months, 43,732 shares of Esperion Therapeutics Inc (ESPR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 43,732 shares.
Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Esperion Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Mirati Therapeutics Inc do?
Who are the key executives at Mirati Therapeutics Inc?
Joseph Lewis is the other: See remarks of Mirati Therapeutics Inc. Other key executives at Mirati Therapeutics Inc include Sr. Vice President & Chief Scie Jamie Christensen , EVP & Chief Commercial Officer Benjamin Hickey , and Interim CFO Aaron Ondrey .
Mirati Therapeutics Inc (MRTX) Insider Trades Summary
Over the past 18 months, Joseph Lewis made no insider transaction in Mirati Therapeutics Inc (MRTX). Other recent insider transactions involving Mirati Therapeutics Inc (MRTX) include a net sale of 7,903 shares made by Jamie Christensen , a net sale of 5,907 shares made by Benjamin Hickey , and a net purchase of 2,517,946 shares made by Boxer Capital, Llc .
In summary, during the past 3 months, insiders sold 0 shares of Mirati Therapeutics Inc (MRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,810 shares of Mirati Therapeutics Inc (MRTX) were sold and 2,528,737 shares were bought by its insiders, resulting in a net purchase of 2,514,927 shares.
Mirati Therapeutics Inc (MRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Mirati Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Sesen Bio Inc do?
Who are the key executives at Sesen Bio Inc?
Joseph Lewis is the 10 percent owner of Sesen Bio Inc. Other key executives at Sesen Bio Inc include 10 percent owner Modernatx, Inc. , director & President and CEO Steven Kelly , and Chief Financial Officer Richard Steven Morris .
Sesen Bio Inc (SESN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sesen Bio Inc (SESN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sesen Bio Inc (SESN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sesen Bio Inc (SESN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sesen Bio Inc Insider Transactions
- Download to Excel(.xls)
What does Sophiris Bio Inc do?
Who are the key executives at Sophiris Bio Inc?
Joseph Lewis is the 10 percent owner of Sophiris Bio Inc. Other key executives at Sophiris Bio Inc include director & President & Chief Exec Officer Randall E Woods , 10 percent owner Boxer Asset Management Inc. , and 10 percent owner Boxer Capital, Llc .
Sophiris Bio Inc (SPHS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sophiris Bio Inc (SPHS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sophiris Bio Inc (SPHS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sophiris Bio Inc (SPHS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sophiris Bio Inc Insider Transactions
- Download to Excel(.xls)
What does Aradigm Corp do?
Who are the key executives at Aradigm Corp?
Joseph Lewis is the 10 percent owner of Aradigm Corp. Other key executives at Aradigm Corp include 10 percent owner Bleichroeder Lp , 10 percent owner First Eagle Investment Management, Llc , and 10 percent owner First Eagle Value In Biotechnology Master Fund, Ltd. .
Aradigm Corp (ARDMQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aradigm Corp (ARDMQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aradigm Corp (ARDMQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aradigm Corp (ARDMQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aradigm Corp Insider Transactions
- Download to Excel(.xls)
What does Rain Oncology Inc do?
Who are the key executives at Rain Oncology Inc?
Joseph Lewis is the other: See remarks. of Rain Oncology Inc. Other key executives at Rain Oncology Inc include 10 percent owner Kevin C Tang , Principal Fin. & Acc. Officer Josephine Bruce , and 10 percent owner Tang Capital Partners Lp .
Rain Oncology Inc (RAIN) Insider Trades Summary
Over the past 18 months, Joseph Lewis made no insider transaction in Rain Oncology Inc (RAIN). Other recent insider transactions involving Rain Oncology Inc (RAIN) include a net purchase of 110,172 shares made by Kevin C Tang ,
In summary, during the past 3 months, insiders sold 0 shares of Rain Oncology Inc (RAIN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 173,973 shares of Rain Oncology Inc (RAIN) were sold and 284,145 shares were bought by its insiders, resulting in a net purchase of 110,172 shares.
Rain Oncology Inc (RAIN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rain Oncology Inc Insider Transactions
- Download to Excel(.xls)
What does Tango Therapeutics Inc do?
Who are the key executives at Tango Therapeutics Inc?
Joseph Lewis is the other: See remarks of Tango Therapeutics Inc. Other key executives at Tango Therapeutics Inc include 10 percent owner Ecor1 Capital, Llc , 10 percent owner Third Rock Ventures Iv, L.p. , and other: See remarks Mva Investors, Llc .
Tango Therapeutics Inc (TNGX) Insider Trades Summary
Over the past 18 months, Joseph Lewis made no insider transaction in Tango Therapeutics Inc (TNGX). Other recent insider transactions involving Tango Therapeutics Inc (TNGX) include a net sale of 2,504,900 shares made by Third Rock Ventures Iv, L.p. , a net purchase of 2,750,000 shares made by Boxer Capital, Llc , and a net sale of 4,588,000 shares made by .
In summary, during the past 3 months, insiders sold 7,288,000 shares of Tango Therapeutics Inc (TNGX) in total and bought 20,000 shares, with a net sale of 7,268,000 shares. During the past 18 months, 10,639,148 shares of Tango Therapeutics Inc (TNGX) were sold and 2,995,000 shares were bought by its insiders, resulting in a net sale of 7,644,148 shares.
Tango Therapeutics Inc (TNGX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tango Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Tyra Biosciences Inc do?
Who are the key executives at Tyra Biosciences Inc?
Joseph Lewis is the 10 percent owner of Tyra Biosciences Inc. Other key executives at Tyra Biosciences Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , Chief Financial Officer Alan Fuhrman , and director & Chief Executive Officer Todd Harris .
Tyra Biosciences Inc (TYRA) Insider Trades Summary
Over the past 18 months, Joseph Lewis made no insider transaction in Tyra Biosciences Inc (TYRA). Other recent insider transactions involving Tyra Biosciences Inc (TYRA) include a net sale of 220,952 shares made by Daniel Bensen , a net sale of 250,000 shares made by Todd Harris , and a net sale of 230,134 shares made by Nina S Kjellson .
In summary, during the past 3 months, insiders sold 363,827 shares of Tyra Biosciences Inc (TYRA) in total and bought 1,230,181 shares, with a net purchase of 866,354 shares. During the past 18 months, 701,086 shares of Tyra Biosciences Inc (TYRA) were sold and 1,230,181 shares were bought by its insiders, resulting in a net purchase of 529,095 shares.
Tyra Biosciences Inc (TYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tyra Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does CARISMA Therapeutics Inc do?
Who are the key executives at CARISMA Therapeutics Inc?
Joseph Lewis is the 10 percent owner of CARISMA Therapeutics Inc. Other key executives at CARISMA Therapeutics Inc include 10 percent owner Modernatx, Inc. , director & President and CEO Steven Kelly , and Chief Financial Officer Richard Steven Morris .
CARISMA Therapeutics Inc (CARM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of CARISMA Therapeutics Inc (CARM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CARISMA Therapeutics Inc (CARM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
CARISMA Therapeutics Inc (CARM)'s detailed insider trading history can be found in Insider Trading Tracker table.
CARISMA Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
Joseph Lewis Mailing Address
Above is the net worth, insider trading, and ownership report for Joseph Lewis. You might contact Joseph Lewis via mailing address: Po Box N7776, Lyford Bahamas.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
